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Abstract 
A measurement system for free hemoglobin in opaque particular liquids was developed. Sophisticated systems for 
specific toxin removal in extracorporeal blood purification are based on particular adsorbent suspensions. In case of 
treatment problems (too high shear forces to erythrocytes) red blood cells are damaged and hemoglobin is released. 
To protect patients from red blood cell damage, a detection device for fHb is needed. A spectroscopic fHb 
measurement system was developed and tested based on light reflection/scattering on the particular suspension. 
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1.Inroduction 
Plasmapheresis and hemoperfusion/plasmaperfusion are detoxification methods that are mainly 
designed to remove protein-bound or hydrophobic substances from the blood. Nevertheless, the mortality 
and morbidity of patients suffering from acute or chronic liver failure can be improved by eliminating 
toxins from the blood which cannot be eliminated using conventional dialysis treatment (hemodialysis, 
hemofiltration) which removes only water-soluble substances [1-5]. We considered, therefore, developing 
a new, inexpensive detoxification method which is both effective and selective in its elimination of 
hydrophobic and protein-bound substances from the blood based on suspended micro adsorbents. The 
Microsphere based Detoxification System (MDS) [6-10] is a device consisting of two circuits connected 
through a hollow-fiber membrane filter (fig. 1). The suspended microparticles, circulating in the 
secondary circuit, can be modified to satisfy various medical requirements by adding different functional 
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groups to the adsorptive outer and inner surface structures for selective removal of toxins. If the 
transmembrane pressure in the plasma filter is too high, the red blood cells can be damaged due to high 
shear forces and therefore hemoglobin is released. To protect the patient from erythrocyte damage, a 
detector for free hemoglobin (fHb) must be placed in the secondary MDS circuit.  
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Fig. 1. Functional principle of the microparticle based detoxification system (MDS). 
2.Sensor design 
In standard plasmapheresis systems, the liquid in the filtrate circuit is transparent where fHb can be 
easily detected by measuring the redness of the media. The redness measurement is typically done by 
calculation of the absorbance ratio of red and green light during transmission through the media according 
to the Lambert–Beer law. As more hemoglobin is present in the filtrate, as higher becomes the absorbance 
of red light during transmission and therefore the absorbance ratio between red and green light changes. 
Typical fHb detectors used in commercial plasmapheresis devices have an fHb alarm threshold of 150mg 
fHb per dl plasma [11]. The developed optical detection system is designed to measure the content of fHb 
in an optical opaque media like in the MDS sorbent circuit. The sensor principle is based on spectroscopic 
measurement of reflected/back scattered light under broad band illumination (400 to 700nm) of the 
adsorbent microparticle suspension [12]. The tubing containing the microparticle suspension is fixed in a 
sensor housing (fig. 2) where it is compressed and flattened in the measurement chamber.  
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Fig. 2. Principle of the optical fHb sensor.  
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At the rear of the housing a white and a green LED light source as well as a tip of a glass fiber for 
collecting the reflected light is placed. The white light source is used for an optical broad band 
illumination of the suspension and the green light source is used for an internal system life/dead test at 
startup. Emitted light passes through the transparent tube wall into the optically dense liquid in the tubing 
and is absorbed, reflected or scattered, depending on the given wavelength. Reflected light from the 
suspension is collected by a collateral placed glass fiber and directed to a spectrometer. During MDS 
treatment, cyclic spectral measurements for fHb detection are done by spectral measurement of the “dark 
spectrum” (all LEDs off) and subsequent spectral measurement of the reflected/scattered light from the 
suspension carrying tubing under illumination of the white measurement LED. The output signal for fHb 
detection S at a certain wavelength Ȝn and at the kth measurement cycle is calculated by eq. 1 and shown in 
fig. 3.  
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The detected light intensity at the spectrometer ș(Ȝn,tk) is measured at the wavelength Ȝn and at the time 
point tk where the kth measurement cycle is running. For calibration, the measurement spectrum and the 
dark spectrum at start up (time point t0) is used. After spectral measurement, the spectral values between 
520nm and 600nm are summarized building the output signal G(tk) (eq. 2) which is linear proportional to 
fHb content in the suspension (fig. 4). 
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3.Conclusions 
A method for optical detection of fHb in opaque particular liquids has been developed. The system design 
is based on spectral measurement of back scattered/reflected light. By integrating the spectrometer output 
signals in the wavelength range from 520nm to 600nm an approximately linear relation to the fHb content 
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Fig. 3. Absorption spectra of the particular fluid containing 
different amounts of fHb. 
Fig. 4. Value of the integrated spectrum for different fHb 
concentrations in the adsorbent suspension. 
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was found. Typical fHb detectors used in commercial plasmapheresis devices have an fHb alarm 
threshold of 150mg fHb per dl plasma which is also clearly achieved by our device.  
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